Follow Us on Google News
KARACHI: More than 150 domestic pharmaceutical companies are on the verge of closure due to the alleged destructive policy of controversial CEO Drap Asim Rauf and Drug Regulatory Authority of Pakistan, which is likely to lead to unemployment of thousands of employees. However, despite paying billions of rupees in taxes, the companies almost came to a standstill.
Surprisingly in this case, despite everything being to the notice of the higher authorities, no action has been taken so far which is a matter of concern while in the next few days it is being speculated that more than 150 national Pharmaceutical companies are considering closing their businesses.
Asim Rauf, who was recruited as a drug inspector in Lahore and then fraudulently appointed as the CEO of Drug Regulatory of Pakistan, destroyed the national companies by colluding with the drug mafia and companies.
Credible sources revealed that Asim Rauf was actually a blue-eyed boy of the ousted CEO of Drap Sheikh Akhtar, who had got the CEO position on the basis of fake documents, and later was removed when his documents proved fake. “Since today, Asif Rauf has been given many promotions out of rules and by violating laws of Drap, and every time he was promoted on the behest of Sheikh Akhtar,” the sources added.
When he was removed on forged documents, the post of acting CEO was handed over to Asim Rauf in collusion, while in the appointment of Asim Rauf, the Cabinet and former Prime Minister Imran Khan were also misled and kept in the dark.
After the appointment of Asim Rauf, it was complained to the Prime Minister that the appointment of CEO and DRAP was against the rules and regulations. However, inquiries regarding the appointment of Asim Rauf were carried out with utmost skill keeping in view all the rules and regulations.
The committee further wrote that all the records were concealed during Asim Rauf’s promotions.
While the drug mafia is engaged in rewarding and allegedly making money and bringing the destruction of domestic companies to the brink, credible sources also say that multinational companies put such wheels under the files to register their new drug themselves. Their medicines and prices are registered in minutes while most of the companies earn crores of rupees per month by promoting their medicines and not allowing the companies in Pakistan to register their medicines.
A portion of which is also given to the senior executives and CEOs of DRAP while the files of domestic pharmaceutical companies are deliberately lost and deliberately delayed so that their medicines do not reach the markets. ۔
Credible sources say that this is the reason why people are willing to pay at least Rs 30-40 crore for CEO DRAP, of which there are examples. Attempts were made to speak to the controversial CEO, Drap Asim Rauf, to find out his position, but he did not pick up the phone.
After which the Inquiry Committee said that the appointment of Asim Rauf and the promotions received by Asim Rauf to date was wrong, in which the rules and regulations were kept in abeyance, the Inquiry Committee further wrote that he was returned to his old scale. To be sent, the Inquiry Committee further suggested that a CEO be appointed on a permanent basis while thirteen directors of DRAP be made permanent.
